DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Tata Steel Limited — Pendency of any litigation(s) or dispute(s)-(Sub-para 8-Para B)

NSE 2 hrs ago·29 Sept 2026, 11:44 am

Tata Steel

Tata Steel has informed the stock exchanges that it is currently involved in pending litigation or disputes. This disclosure relates to a specific sub-clause of a regulatory filing, highlighting that the company is not currently free from all legal proceedings.

For investors, this news serves as a routine update rather than a major financial shock. While the exact nature of the disputes is not detailed in this brief filing, it is a standard disclosure requirement for listed companies to inform the market about any ongoing legal challenges. It ensures transparency and allows shareholders to stay informed about the company's risk profile.

Investors should monitor the company's future disclosures to understand the potential financial impact of these disputes. It is important to wait for further details or official statements from the company before drawing any conclusions about the stock's performance.